The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Presentation and management of patients with brain metastases of primary melanoma, non-small cell lung cancer, and breast cancer origin.
 
Yuki Kawahara
No Relationships to Disclose
 
Matthew Mills
No Relationships to Disclose
 
Thrisha Potluri
No Relationships to Disclose
 
Matthew Fahey
No Relationships to Disclose
 
Nicholas B Figura
No Relationships to Disclose
 
Aixa Soyano
No Relationships to Disclose
 
Iman Washington
No Relationships to Disclose
 
Roberto Diaz
No Relationships to Disclose
 
Daniel Eli Oliver
No Relationships to Disclose
 
Hsiang-Hsuan Michael Yu
Honoraria - Brainlab
Consulting or Advisory Role - Abbvie; Novocure
 
Arnold B. Etame
No Relationships to Disclose
 
Michael A. Vogelbaum
Stock and Other Ownership Interests - Infusion Therapeutics
Honoraria - Celgene; Cellinta; Tocagen
Research Funding - Celgene (Inst); Infusion Therapeutics (Inst); Oncosynergy (Inst)
Patents, Royalties, Other Intellectual Property - Patents for drug delivery devices for the brain
 
Brian J. Czerniecki
No Relationships to Disclose
 
John Arrington
No Relationships to Disclose
 
Solmaz Sahebjam
Stock and Other Ownership Interests - Abbvie; Allergan
Consulting or Advisory Role - Boehringer Ingelheim; Merck
Research Funding - Bristol-Myers Squibb (Inst); Brooklyn ImmunoTherapeutics (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Lilly
 
Hatem Hussein Soliman
Consulting or Advisory Role - AstraZeneca; Celgene; Eisai; Immunomedics; Novartis; Puma Biotechnology; Seagen
Speakers' Bureau - Sanofi
Research Funding - Amgen (Inst)
Patents, Royalties, Other Intellectual Property - Celeyad licensing agreement (Inst)
 
Peter A. J. Forsyth
Honoraria - Abbvie; BTG; Novocure
Consulting or Advisory Role - Abbvie; Boehringer Ingelheim; BTG; Novocure; Tocagen; ZIOPHARM Oncology
Research Funding - Bankhead-Coley Cancer Research; Department of Defense; Florida Academic Cancer Center Alliance; NIH/NCI; Pfizer
Travel, Accommodations, Expenses - Abbvie; Bayer; Bristol-Myers Squibb; BTG; Inovio Pharmaceuticals; National Cancer Research Institute (NCRI); NCI; NIH; Physical Sciences Oncology Network
 
Hyo S. Han
Consulting or Advisory Role - Pfizer
Speakers' Bureau - Lilly
Research Funding - Abbvie (Inst); Arvinas (Inst); Bristol-Myers Squibb (Inst); Department of Defense (Inst); G1 Therapeutics (Inst); GlaxoSmithKline (Inst); Horizon Oncology Research (Inst); Marker Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Prescient Therapeutics (Inst); QuantumLeap Health (Inst); Seagen (Inst); Zymeworks (Inst)
 
Kamran A. Ahmed
Honoraria - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst)